Biotest AG — Director's Dealing 2009

May 18, 2009

News Details

Directors’ Dealings | 18 May 2009 10:01

DGAP-DD: Biotest AG english

Notification concerning transactions by persons performing managerial responsibilities pursuant to section 15a of the WpHG Directors’ Dealings notification transmitted by DGAP – a company of EquityStory AG. The person with duty of notification is solely responsible for the content of this announcement. —————————————————————————— Details of the person subject to the disclosure requirement Last name: Dr. Pabst First name: Rainer Company: Biotest Pharmaceuticals Corporation Position: General Manager Biotest Pharmaceuticals Corp. USA Information about the transaction with duty of notification Description of the financial instrument: Preference Shares ISIN/WKN of the financial instrument: DE0005227235 Type of transaction: Buy Date: 15.05.2009 Price: 31.71 Currency: EUR No. of items: 675 Total amount traded: 21400.95 Place: Xetra Explanation for publication: 606 Shares quote 31,70 69 Shares quote 31,75 Information about the company with duty of publication Issuer: Biotest AG Landsteinerstraße 5 63303 Dreieich Deutschland ISIN: DE0005227235 WKN: 522723 End of Directors’ Dealings Notification (c) DGAP 18.05.2009 Financial News transmitted by DGAP ID 9486